Clinical Trials Browser

Hematologic Neoplasms × baloxavir × 90 days × Clear all

NCT04712539 2026-02-11

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

Phase 2 Recruiting

Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms